Results 11 to 20 of about 2,566,443 (193)

Treatment approaches and adherence to urate-lowering therapy for patients with gout [PDF]

Patient Preference and Adherence, 2017
Thanda Aung,* Gihyun Myung,* John D FitzGerald Division of Rheumatology/Department of Internal Medicine, University of California, Los Angeles, Los Angeles, CA, USA *These authors contributed equally to this work Abstract: Gout is the most common ...
Aung T, Myung G, FitzGerald JD
doaj   +11 more sources

Spinal gout recovery with urate‐lowering therapy: A case report [PDF]

Clinical Case Reports
Key Clinical Message The occurrence of spinal gout resulting in erosion of the superior articular process in patients with low back pain is uncommon, potentially leading to misdiagnosis and inappropriate treatment.
Kunfang Huo, Jialin Zhang, Yanhua Lin, Qianyun Chen, Han Zhong, Bin Yang   +5 more
doaj   +5 more sources

Controversies in Urate-Lowering Therapy for Gout: A Comprehensive Review [PDF]

Gout, Urate, and Crystal Deposition Disease
Gout is the most common inflammatory arthritis. Treatment of gout includes anti-inflammatory and urate-lowering agents. Robust guidelines by the American College of Rheumatology, the European Alliance of Associations for Rheumatology and other committees
Michael Pillinger, Michael Toprover
exaly   +3 more sources

Urate-lowering therapy for asymptomatic hyperuricaemia: A need for caution

Seminars in Arthritis and Rheumatism, 2017
The observed associations of hyperuricaemia with hypertension, cardiovascular disease and kidney disease are receiving increasing interest. The potential role of urate-lowering therapy in the management of these "non-gout diseases" has been raised, and in some countries it is already recommended.
Lisa Stamp, Nicola Dalbeth
exaly   +5 more sources

Urate-lowering therapy for patients with gout on hemodialysis. [PDF]

Int J Rheum Dis, 2022
AbstractObjectiveGout is the most common form of inflammatory arthritis and is caused by deposition of monosodium urate crystals resulting from a high burden of uric acid (UA). High UA burden also has been associated with increased morbidity and mortality in the general population and progression to chronic kidney disease.
Alkilany R, Einstadter D, Antonelli M.
europepmc   +3 more sources

Should all people starting urate-lowering therapy for gout receive anti-inflammatory prophylaxis? [PDF]

Exploration of Musculoskeletal Diseases
Co-prescription of anti-inflammatory prophylaxis with colchicine, non-steroidal anti-inflammatory drugs (NSAIDs), or corticosteroids when initiating urate-lowering therapy (ULT) for gout is recommended in clinical guidelines to prevent ULT-induced flares
Edward Roddy, James A. Prior, Christian D. Mallen   +2 more
doaj   +2 more sources

Urate-lowering therapy modifies associations between urinary urate and kidney outcome [PDF]

Renal Failure
Background Serum uric acid is associated with chronic kidney disease (CKD) progression; however, causality remains uncertain. Although renal urate handling, rather than merely hyperuricemia, may dominate kidney outcomes, the prognostic value of urinary ...
Tomoaki Takata, Yukari Mae, Shotaro Hoi, Naoyuki Otani, Takaaki Sugihara, Ichiro Hisatome, Hajime Isomoto   +6 more
doaj   +2 more sources

Personalized Medicine of Urate-Lowering Therapy for Gout [PDF]

, 2020
Gout is a common and complex form of arthritis that is characterised with hyperuricaemia. It is required urate-lowering therapy (ULT) for lifelong management. ULT includes decreasing uric acid product in serum, increasing renal urate excretion and promoting uric acid to allantoin for excretion.
Zhang, Y, Yan, D
openaire   +3 more sources

Factors associated with initiation and persistence of urate-lowering therapy [PDF]

Arthritis Research & Therapy, 2017
Gout is the most common inflammatory arthritic disease and is caused by crystal deposition secondary to persistent hyperuricemia. Etiological treatment with urate-lowering therapy (ULT) has been available since the 1950s but previous studies have demonstrated suboptimal degree of treatment.
Mats Dehlin, Emin Hoxha Ekström, Max Petzold, Ulf Strömberg, Gunilla Telg, Lennart T. H. Jacobsson   +5 more
openaire   +4 more sources

Perceptions About Asymptomatic Hyperuricemia and Views About Urate-Lowering Therapy in People With Asymptomatic Hyperuricemia. [PDF]

Arthritis Care Res (Hoboken)
BACKGROUND/AIMS: Asymptomatic hyperuricemia is a precursor of gout and is also associated with cardiovascular disease and chronic kidney disease. The aim of this study was to understand perceptions about asymptomatic hyperuricemia and views about urate ...
Dalbeth N, Stewart S, Gamble GD, Mihov B, Stamp LK, Haslett J, Taylor WJ, Merriman TR, Tabi-Amponsah AD, Horne A, Neogi T, Pascart T, Andrés M, Peral-Garrido ML, Norkuviene E, Vazquez-Mellado J, Uhlig T, Sun M, Li C, Petrie KJ.   +19 more
europepmc   +2 more sources